Dermagnostix GmbH

DermagnostixModel PsorX-LabDisk - Molecular Diagnostics Tool for Psoriasis and Eczema

SHARE

Dermagnostix introduces the PsorX-LabDisk, a cutting-edge molecular diagnostic tool that significantly enhances the accuracy of diagnosing psoriasis and eczema. Distinct from traditional subjective methods, which often lead to misdiagnosis due to overlapping symptoms, the PsorX-LabDisk provides an objective, gene expression-based test that ensures precision in differential diagnosis. The fully automated, 'Lab-in-a-Box' system streamlines the entire diagnostic process within a closed platform, requiring minimal manual intervention and offering results in as little as two hours. Developed and manufactured in Germany, this device leverages centrifugal microfluidics to facilitate efficient fluid movement and compartmentalization within its cartridges, which contain all necessary reagents for accurate performance. The PsorX-LabDisk mitigates the challenges of space and training seen in traditional PCR processes, thus enhancing efficiency and providing dermatopathology laboratories with reliable, contaminant-free results.

Most popular related searches
  • Cutting edge: The first gene expression based test for the differential diagnosis of psoriasis and eczema.
  • Fast: Full automation allows for minimal hands-on-time: Sample in, answer out in 1-2 hours
  • Simple Plug and Play System: Centrifugal microfluidics-based “Lab-in-a-Box” platform ready for immediate use. 
  • Objective: PsorX-LabDisk provides objective accurate aid in differential diagnosis of eczema and psoriasis
  • Made in Germany: Our products are developed and produced in Germany in compliance with IVD(R) requirements. 

More Objectivity and Precision for Your Diagnostics

Psoriasis and eczema are two of the most common inflammatory skin diseases, yet up to 50% of cases present diagnostic challenges1,2 due to significant overlap in both clinical and histopathologic features. This uncertainty complicates treatment, as modern therapies like biologicals and small-molecule inhibitors, tailored specifically for either psoriasis or eczema, may not reach their full potential and could even laggravate the disease in case of misdiagnosis. Traditional dermatological diagnostics are based on subjective evaluation, which can result in misdiagnosis, and dissatisfied patients.

Dermagnostix fills the diagnostic gap with its innovative PsorX-LabDisk (CE-IVD). It complements histopathological assessment by offering objective molecular diagnostics in dermatopathology, distinguishing psoriasis from eczema with high precision independent of individual users or their daily performance. Our technology enables the differential diagnosis between psoriasis and eczema, reducing uncertainty and guiding effective treatment. PsorX-LabDisk revolutionizes diagnostics – benefiting both patients and laboratory efficiency.

Elevate your dermatopathology laboratory with molecular diagnostics – contact us today to learn more!

Our advanced molecular diagnostics for dermatopathology are performed using the PsorX-LabDisk, a fully automated, single-use cartridge that contains all the necessary reagents for precise assay performance. The LabDisk together with the LabDisk-Analyzer compresses a complete molecular laboratory into one closed platform, seamlessly carrying out every step of the diagnostic process – from sample purification to signal detection – without manual intervention and without risk of contamination.

Unlike traditional manual PCR processes that can take several days and require substantial laboratory space and skilled personnel, our system delivers results in just 2 hours and requires only limited space and minimal training.